The Patent Finder

Biovail Corporation

Also on record
Records under this name other than patents Biovail Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Biovail Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,676,966Extended Release Metformin Hydrochloride Formulations
Formerly held
Term ended
Ended no later than Nov 10, 2021 · Medium confidence
Term endedEnded no later than Nov 10, 2021Medium confidence
US 6,033,686Controlled release tablet of bupropion hydrochloride
Formerly held
Term ended
Term ended Oct 30, 2018 · USPTO record
Term endedTerm ended Oct 30, 2018USPTO record
US 6,165,512Dosage forms containing taste masked active agents
Formerly held
Term ended
Term ended Oct 30, 2018 · USPTO record
Term endedTerm ended Oct 30, 2018USPTO record
US 6,312,724Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
Formerly held
Term ended
Term ended Apr 3, 2018 · USPTO record
Term endedTerm ended Apr 3, 2018USPTO record
US 6,893,661Controlled release formulations using intelligent polymers
Formerly held
Term ended
Term ended Apr 3, 2018 · USPTO record
Term endedTerm ended Apr 3, 2018USPTO record
US 6,417,886Image transmission apparatus and method and image transmission system
Formerly held
Term ended
Term ended Feb 20, 2018 · USPTO record
Term endedTerm ended Feb 20, 2018USPTO record
US 6,967,218Pravastatin Pharmaceutical Formulations and Methods of Their Use
Formerly held
Lapsed on the fee record
Ended Nov 22, 2017 · High confidence
Lapsed on the fee recordEnded Nov 22, 2017High confidence
US 6,517,886Positive hydration method of preparing confectionery and the resulting product
Formerly held
Term ended
Ended no later than Jun 24, 2017 · USPTO record
Term endedEnded no later than Jun 24, 2017USPTO record
US 6,509,037Sustained Release Pharmaceutical Matrix Tablet of Pharmaceutically Acceptable Salts of Diclofenac and Process for Preparation Thereof
Formerly held
Lapsed on the fee record
Ended Jan 21, 2015 · Medium confidence
Lapsed on the fee recordEnded Jan 21, 2015Medium confidence
US 6,733,789Multiparticulate bisoprolol formulation
Formerly held
Lapsed on the fee record
Ended May 11, 2012 · USPTO record
Lapsed on the fee recordEnded May 11, 2012USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited